GlassScriptPhysician profile
Jacob Venesky
NPI 1437561016
$1,561.94
in general payments reported to CMS, 2019-2025
14 companies · $1,007 in 2025
The $1,007 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.84 · 2020: $80.73 · 2021: $53.09 · 2022: $248 · 2023: $147 · 2025: $1,007.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $917 · Food and Beverage: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $916.97 |
| Food and Beverage | $236.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $937.55 | 2025 | |
| Astellas Pharma US INC | $216.77 | 2022-2025 | Veozah |
| Exeltis, USA INC. | $79.35 | 2022 | |
| Abbvie INC. | $72.98 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.08 | 2019-2025 | |
| Novo Nordisk INC | $32.29 | 2021-2022 | |
| Therapeuticsmd, INC. | $30.44 | 2019-2022 | |
| Scynexis, INC. | $25.11 | 2022 | |
| Organon LLC | $24.40 | 2023 | Nexplanon |
| Mayne Pharma Commercial LLC | $23.49 | 2023 | |
| Aspira Women'S Health INC | $20.46 | 2023 | Ova1 |
| Merck Sharp & Dohme LLC | $18.85 | 2020 | |
| Coopersurgical, INC. | $12.90 | 2021 | |
| Lilly USA, LLC | $11.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Venesky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.